SMG-1 serves as a prognostic indicator for the radiotherapy response in head and neck squamous cell carcinoma xenografts and patients

Xiaofeng Wang; Yuxia Zou; Ren-Bo Ding; Xueying Lyu; Yuanfeng Fu; Xuejun Zhou; Zhihua Sun; Jiaolin Bao

doi:10.3724/abbs.2024180

SMG-1 serves as a prognostic indicator for the radiotherapy response in head and neck squamous cell carcinoma xenografts and patients

Acta Biochim Biophys Sin (Shanghai). 2024 Nov 4;56(12):1891-1894. doi: 10.3724/abbs.2024180.

Authors

Xiaofeng Wang¹, Yuxia Zou¹, Ren-Bo Ding², Xueying Lyu³, Yuanfeng Fu², Xuejun Zhou¹, Zhihua Sun^{2

4}, Jiaolin Bao²

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Hainan Medical University, Haikou 571199, China.
² Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
³ Cancer Centre, Faculty of Health Sciences, University of Macau, Macao 999078, China.
⁴ College of Animal Science and Technology, Shihezi University, Shihezi 832003, China.

No abstract available

Grants and funding

This work was supported by the grants from the Hainan Provincial Natural Science Foundation of China (Nos. 820MS141, 822RC831, 822QN300, and 822RC649), the National Natural Science Foundation of China (Nos. 82104057, 82360504, and 82203206), the Hainan University Collaborative Innovation Center Research Fund (No. XTCX2022JKB01), and the Hainan “Nanhai New Star” Project (No. 202309009).